Differential patterns of allelic loss in estrogen receptor‐positive infiltrating lobular and ductal breast cancer
暂无分享,去创建一个
C I Li | P. Porter | L. Loo | L. Hsu | J. Daling | H. Bouzek | P L Porter | J R Daling | L. Hsu | C. Ton | D. Grove | K E Malone | Lenora W. M. Loo | L W M Loo | C Ton | Y-W Wang | D I Grove | H Bouzek | N Vartanian | M-G Lin | X Yuan | T L Lawton | L Hsu | C. Li | X. Yuan | K. Malone | M.-G. Lin | Y-W Wang | N. Vartanian | T. Lawton | J. R. Daling | K. Malone | Peggy L. Porter | J. R. Daling | Christopher I. Li | Carl C. Ton | Y. W. Wang | Heather Bouzek | Ming-Gang Lin | Xiaopu Yuan | T. L. Lawton
[1] S. Hsu,et al. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.
[2] H. Kuniyasu,et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma , 2005, Oncogene.
[3] P. Rabinovitch,et al. Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. , 1996, Cytometry.
[4] W. Bodmer,et al. THE FREQUENCY AND MECHANISM OF LOSS OF HETEROZYGOSITY ON CHROMOSOME 11q IN BREAST CANCER , 1996, The Journal of pathology.
[5] Stefan Handt,et al. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization , 2001, The Journal of pathology.
[6] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[7] R Anbazhagan,et al. Allelic loss of chromosomal arm 8p in breast cancer progression. , 1998, The American journal of pathology.
[8] Funda Meric-Bernstam,et al. BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. , 2006, Cancer cell.
[9] S. Devries,et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma , 2004, Cancer.
[10] P. Porter,et al. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. , 1999, Journal of the National Cancer Institute.
[11] P. Porter,et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. , 2003, JAMA.
[12] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[13] R. Cote,et al. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques , 1994, Human pathology.
[14] P. O’Connell,et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.
[15] P. Newcomb,et al. Hormone replacement therapy in relation to breast cancer. , 2002, JAMA.
[16] S. Ichihara,et al. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast. , 2000, Cancer letters.
[17] Lei Xu,et al. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[18] H Buerger,et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes , 1999, The Journal of pathology.
[19] David Botstein,et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.
[20] Jane Fridlyand,et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.
[21] David J. Chen,et al. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro. , 2003, Cancer research.
[22] Ajay N. Jain,et al. Breast tumor copy number aberration phenotypes and genomic instability , 2006, BMC Cancer.
[23] Xingzhi Xu,et al. Microcephalin Is a DNA Damage Response Protein Involved in Regulation of CHK1 and BRCA1*♦ , 2004, Journal of Biological Chemistry.
[24] A. Thor,et al. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.
[25] Cheng Li,et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..
[26] C. Croce,et al. Loss of heterozygosity at 11q22-q23 in breast cancer. , 1994, Cancer research.
[27] O. Pereira-smith,et al. Primary and Compensatory Roles for RB Family Members at Cell Cycle Gene Promoters That Are Deacetylated and Downregulated in Doxorubicin-Induced Senescence of Breast Cancer Cells , 2006, Molecular and Cellular Biology.
[28] E. Gabrielson,et al. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. , 1996, Cancer research.
[29] B. Anderson,et al. Trends in incidence rates of invasive lobular and ductal breast carcinoma. , 2003, JAMA.
[30] G. Hortobagyi,et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] E. Yıldırım,et al. Is invasive lobular carcinoma different from invasive ductal carcinoma? , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[32] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[33] A. Jaiswal,et al. Involvement of adenomatous polyposis coli in colorectal tumorigenesis. , 2005, Frontiers in bioscience : a journal and virtual library.
[34] H. Poulsen,et al. Immunohistochemical estrogen receptor determination in paraffin‐embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer , 1989, Cancer.
[35] P. Porter,et al. Relationship between Menopausal Hormone Therapy and Risk of Ductal, Lobular, and Ductal-Lobular Breast Carcinomas , 2008, Cancer Epidemiology Biomarkers & Prevention.
[36] Junko Oshima,et al. WRN, the protein deficient in Werner syndrome, plays a critical structural role in optimizing DNA repair , 2003, Aging cell.
[37] C. Aldaz,et al. WWOX, a chromosomal fragile site gene and its role in cancer. , 2006, Advances in experimental medicine and biology.
[38] N. Carter,et al. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH , 2006, Oncogene.
[39] David L. Page,et al. Diagnostic Histopathology of the Breast , 1988 .
[40] M. Vijver,et al. E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.
[41] John Robbins,et al. National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.
[42] G. Zachos,et al. Chk1 Requirement for High Global Rates of Replication Fork Progression during Normal Vertebrate S Phase , 2006, Molecular and Cellular Biology.
[43] Shane Herbert,et al. Whole genome SNP arrays using DNA derived from formalin‐fixed, paraffin‐embedded ovarian tumor tissue , 2005, Human mutation.
[44] P. Devilee,et al. Somatic genetic changes in human breast cancer. , 1994, Biochimica et biophysica acta.
[45] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[46] Sridhar Ramaswamy,et al. Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers , 2004, Cancer Research.
[47] Barbara J. Trask,et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.
[48] C. Counter,et al. Characterization of Interactions between PinX1 and Human Telomerase Subunits hTERT and hTR* , 2004, Journal of Biological Chemistry.
[49] K. Rogers,et al. Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology. , 1988, Journal of clinical pathology.
[50] R. Elledge,et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome , 2004, Breast Cancer Research.
[51] A. Hanby,et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. , 1999, Cancer research.
[52] W. Willett,et al. Breast cancer (1) , 1992, The New England journal of medicine.